Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Dabigatran etexilate 💬
(Dabigatran etexilate (USAN/INN))
[1] Dabigatran etexilate (Dabigatran etexilate mesilate)[1] Dabigatran etexilate[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[2] 51, 75 💬
2 Dabigatran etexilate mesylate 💬
(Dabigatran etexilate mesylate (USAN), Dabigatran etexilate methanesulfonate (JAN), Dabigatran etexilate mesilate, DABIGATRAN ETEXILATE)
[1] Dabigatran etexilate (Dabigatran etexilate mesilate)[1] Dabigatran etexilate[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[2] 51, 75 💬